Watch: Vaccine maker Biological E submits phase 3 trial data

Biological E has submitted the data of phase 3 trials.

Biological E had earlier reportedly sought approval from Indian drug regulators to conduct the third-phase clinical trial of its Covid-19 vaccine that would serve as a booster dose for those who are fully vaccinated with Covishield and Covaxin.